Latest Transformation News

EML Payments reported a 6% revenue decline and an 18% drop in underlying EBITDA for FY26, completing a major restructuring and advancing its Arlo technology platform. The company projects FY27 EBITDA between $50 million and $54 million, with a strong new program pipeline and strategic investments underpinning growth.

Sims Limited delivered a striking FY26 turnaround with net profit soaring 1391%, driven by strong metals trading and a booming technology lifecycle services segment, while advancing sustainability and strategic acquisitions.

Amplitude Energy (ASX:AEL) posted record production and earnings for FY26, underpinned by strong operational execution and progress on the East Coast Supply Project (ECSP). The company strengthened its balance sheet, reduced net debt by 85%, and targets first gas from ECSP in 2028.

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

SRG Global reported record FY26 results driven by strong operational delivery, strategic acquisition of TAMS, and enhanced sustainability governance. The company upgraded its FY27 EBITDA guidance to $195–205 million, supported by a $5.1 billion work in hand and $11.5 billion opportunity pipeline.

Scott Technology has locked in NZ$20 million worth of new Materials Handling & Logistics contracts across North America and Europe, reinforcing its Destination 2030 growth strategy and building on strong FY26 momentum.

Stelar Metals has cleared all statutory hurdles and locked in an experienced driller to launch its maiden 3,500m RC drilling campaign at the Hill of Leaders Tungsten Project within weeks, targeting exceptionally high-grade tungsten mineralisation.

Amcor’s FY2026 results reflect the full impact of its 2025 Berry Global acquisition, with net sales soaring 57% to $23.5 billion and net income more than doubling to $1.1 billion. The company also announced a fiscal year-end change and a raised dividend.

OncoSil Medical has won FDA Humanitarian Device Exemption approval for its OncoSil™ device to treat distal cholangiocarcinoma, opening a US market estimated at A$80 million annually.

Aurizon lifted FY2026 underlying EBITDA by 9% to $1.72 billion, boosted by strong Bulk growth and regulatory gains, while locking in a major Queensland coal haulage contract with BHP Mitsubishi Alliance.

Macmahon Holdings has agreed to sell a partial stake in its Homeground accommodation village to Allcap Securities, aligning itself with a $20 billion infrastructure push in Gladstone. The deal opens doors for Macmahon to tap into civil contracting opportunities linked to the massive Project Velocity.

BlueScope Steel posted a remarkable 857% jump in reported NPAT to $802 million for FY2026, underpinned by strong US spreads, cost discipline, and growth in value-added steel products. The company declared record dividends and advanced key decarbonisation projects, signaling a confident transition from investment to shareholder returns.